Table 2.
Comparisons Across Pharmacological Classes of the Augmentation Medications to the Study Patients (n=38; 39.2%) Who Was Prescribed with Augmentation Medications. The Numbers of Patients Prescribed a Medication in Each Pharmacological Class and the Particular Medication in Each Pharmacological Class
| Pharmacological Class of Augmentation Medications | Medication Name | Number of Patients (%)§ Using the Medication During the Study Period |
|---|---|---|
| Atypical antipsychotic | 21 (55.3%) | |
| Amisulpride | 1 | |
| Olanzapine | 4 | |
| Quetiapine | 20 | |
| Risperidone | 2 | |
| Zotepine | 1 | |
| Mood stabilizer | 4 (10.5%) | |
| Carbamazepine | 1 | |
| Lamotrigine | 1 | |
| Lithium | 1 | |
| Valproic acid | 1 | |
| Psychostimulant | 2 (5.3%) | |
| Methylphenidate | 2 | |
| Typical antipsychotic | 18 (21.1%) | |
| Chlorpromazine | 1 | |
| Sulpiride | 17 | |
| Trifluoperazine | 1 | |
| Thyroid preparation | 1 (2.6%) | |
| Levothyroxine | 1 |
Notes: §patients may be prescribed with more than one medication as augmentation.